These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1631 related articles for article (PubMed ID: 14645149)

  • 1. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
    Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
    Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
    Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
    Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation mechanisms of retinal pigment epithelial cell migration by the TGF-beta superfamily.
    Mitsuhiro MR; Eguchi S; Yamashita H
    Acta Ophthalmol Scand; 2003 Dec; 81(6):630-8. PubMed ID: 14641267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pluripotency gene expression and growth control in cultures of peripheral blood monocytes during their conversion into programmable cells of monocytic origin (PCMO): evidence for a regulatory role of autocrine activin and TGF-β.
    Ungefroren H; Hyder A; Hinz H; Groth S; Lange H; El-Sayed KM; Ehnert S; Nüssler AK; Fändrich F; Gieseler F
    PLoS One; 2015; 10(2):e0118097. PubMed ID: 25707005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenoviral gene transfer allows Smad-responsive gene promoter analyses and delineation of type I receptor usage of transforming growth factor-beta family ligands in cultured human granulosa luteal cells.
    Kaivo-Oja N; Mottershead DG; Mazerbourg S; Myllymaa S; Duprat S; Gilchrist RB; Groome NP; Hsueh AJ; Ritvos O
    J Clin Endocrinol Metab; 2005 Jan; 90(1):271-8. PubMed ID: 15483083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7.
    Inman GJ; Nicolás FJ; Callahan JF; Harling JD; Gaster LM; Reith AD; Laping NJ; Hill CS
    Mol Pharmacol; 2002 Jul; 62(1):65-74. PubMed ID: 12065756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial expression patterns of activin and its signaling system in the zebrafish ovarian follicle: evidence for paracrine action of activin on the oocytes.
    Wang Y; Ge W
    Biol Reprod; 2003 Dec; 69(6):1998-2006. PubMed ID: 12930712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibins are the major activin ligands expressed during early thymocyte development.
    Licona P; Chimal-Monroy J; Soldevila G
    Dev Dyn; 2006 Apr; 235(4):1124-32. PubMed ID: 16477644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of responsiveness to TGF-beta1 in a thyroid carcinoma cell line with functional type I and type II TGF-beta receptors and Smad proteins, suggests a novel mechanism for TGF-beta insensitivity in carcinoma cells.
    Heldin NE; Bergström D; Hermansson A; Bergenstråhle A; Nakao A; Westermark B; ten Dijke P
    Mol Cell Endocrinol; 1999 Jul; 153(1-2):79-90. PubMed ID: 10459856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors.
    Goumans MJ; Valdimarsdottir G; Itoh S; Rosendahl A; Sideras P; ten Dijke P
    EMBO J; 2002 Apr; 21(7):1743-53. PubMed ID: 11927558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.
    Fanayan S; Firth SM; Baxter RC
    J Biol Chem; 2002 Mar; 277(9):7255-61. PubMed ID: 11751851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness.
    Piccirillo CA; Letterio JJ; Thornton AM; McHugh RS; Mamura M; Mizuhara H; Shevach EM
    J Exp Med; 2002 Jul; 196(2):237-46. PubMed ID: 12119348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effect of activin A and BMP-7 on myofibroblast differentiation and the role of the Smad signaling pathway.
    You L; Kruse FE
    Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):72-81. PubMed ID: 11773015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation regulation of the interaction between Smad7 and activin type I receptor.
    Liu X; Nagarajan RP; Vale W; Chen Y
    FEBS Lett; 2002 May; 519(1-3):93-8. PubMed ID: 12023024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.
    Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P
    Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling.
    Goumans MJ; Valdimarsdottir G; Itoh S; Lebrin F; Larsson J; Mummery C; Karlsson S; ten Dijke P
    Mol Cell; 2003 Oct; 12(4):817-28. PubMed ID: 14580334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of TGF-beta, the TGF-beta type I receptor and the R-II receptor in peripheral nerves and mechanoreceptors; observations on changes after traumatic injury.
    Stark B; Carlstedt T; Risling M
    Brain Res; 2001 Sep; 913(1):47-56. PubMed ID: 11532246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
    Poncelet AC; de Caestecker MP; Schnaper HW
    Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor beta1 regulates follistatin mRNA expression during in vitro bovine granulosa cell differentiation.
    Fazzini M; Vallejo G; Colman-Lerner A; Trigo R; Campo S; Barañao JL; Saragüeta PE
    J Cell Physiol; 2006 Apr; 207(1):40-8. PubMed ID: 16245315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 82.